A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with numerous of participants share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.
Some experts stated the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Response and Material Removal
According to TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or administering at residence.
After minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these communities, messages show dark colored parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious health risks”.
